Radiation Protection Dosimetry · 2010 · 25 citations · 18 references
MedicineNuclear MedicineOncologyBiomedical ImagingGenitourinary OncologyUrologic OncologyBiomarkers In Urologic OncologyHepatobiliary ImagingProstate CancerProstate Cancer ImagingProstate ImagingProstate-specific Antigen TestingBiodistribution Of Imaging AgentsCholine ImagingPharmacokinetics Of Imaging ProbesProstate Cancer RecurrenceProstate-specific Antigen KineticsRadioligand PharmacokineticsRadiopharmaceutical PharmacokineticsWhole-body Pet Imaging
Biokinetic data are important when calculating the absorbed dose to the patients and can also be used to find the optimal time between injection and imaging. To the authors' knowledge, there are no published biokinetic data in humans for (18)F-choline, except some distribution data at single time points. Four patients with suspicion of metastases due to biochemical recurrence (measurable prostate-specific antigen in plasma) after radical prostatectomy were injected with (18)F-choline. Four whole-body PET/CT images were taken with 1 h interval, starting immediately after injection. Blood samples were taken and all urine was collected for 3.5 h. The corrected decay activity content in the kidneys was 22-37 % higher immediately after injection when compared with the later time points. The highest activity concentration was found in kidneys (43 kBq ml(-1)). The organ with highest activity content was the liver (11 % of injected activity, % IA). Thirty minutes after the injection 4-16 % IA was left in the blood. Less than 9 % IA was excreted with the urine during the first 3.5 h after injection.
18
Prediction of blood volume in normal human adults.
S. B. Nadler, Ted Bloch · PubMed · 1962 · 2.1K citations
Pharmacy, Hematology, Physiology +12
PET imaging of prostate cancer using carbon-11-choline.
Toshihiko Hara, N Kosaka, Hirofumi Kishi · PubMed · 1998 · 520 citations
Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers.
Timothy R. DeGrado, S. W. BALDWIN, S Wang et al. · PubMed · 2001 · 334 citations
Medicine, Oncology, Pharmacology +14